ID   SF763
AC   CVCL_6949
SY   SF-763; SF 763
DR   BTO; BTO_0004215
DR   cancercelllines; CVCL_6949
DR   CCRID; 1101HUM-PUMC000050
DR   Cosmic; 849885
DR   Cosmic; 1175818
DR   Cosmic; 1217677
DR   Cosmic; 2367500
DR   Wikidata; Q54952932
RX   PubMed=10416987;
RX   PubMed=22570425;
WW   Provider; UCSF; -; https://web.archive.org/web/20150905213317/btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Leu (c.473G>T); ClinVar=VCV000528248; Zygosity=Unspecified (PubMed=10416987).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): CCRID=1101HUM-PUMC000050; PubMed=22570425
ST   Amelogenin: X
ST   CSF1PO: 9 (PubMed=22570425)
ST   CSF1PO: 9,10 (CCRID=1101HUM-PUMC000050)
ST   D13S317: 10,12
ST   D16S539: 10
ST   D18S51: 16
ST   D19S433: 13,15
ST   D21S11: 27,30
ST   D2S1338: 19
ST   D3S1358: 15 (PubMed=22570425)
ST   D3S1358: 15,20 (CCRID=1101HUM-PUMC000050)
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta D: 11,12
ST   Penta E: 5,13
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
RX   PubMed=10416987; DOI=10.1111/j.1750-3639.1999.tb00536.x; PMCID=PMC8098486;
RA   Ishii N., Maier D., Merlo A., Tada M., Sawamura Y., Diserens A.-C.,
RA   Van Meir E.G.;
RT   "Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor
RT   suppressor genes in human glioma cell lines.";
RL   Brain Pathol. 9:469-479(1999).
//
RX   PubMed=22570425; DOI=10.1093/neuonc/nos072; PMCID=PMC3367844;
RA   Bady P., Diserens A.-C., Castella V., Kalt S., Heinimann K.,
RA   Hamou M.-F., Delorenzi M., Hegi M.E.;
RT   "DNA fingerprinting of glioma cell lines and considerations on
RT   similarity measurements.";
RL   Neuro-oncol. 14:701-711(2012).
//